These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25986588)

  • 41. The impact of gastrointestinal mucus on nanoparticle penetration - in vitro evaluation of mucus-penetrating nanoparticles for photodynamic therapy.
    Mahlert L; Anderski J; Mulac D; Langer K
    Eur J Pharm Sci; 2019 May; 133():28-39. PubMed ID: 30885784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin loaded mucus permeating nanoparticles: Addressing the surface characteristics as feature to improve mucus permeation.
    Pereira de Sousa I; Moser T; Steiner C; Fichtl B; Bernkop-Schnürch A
    Int J Pharm; 2016 Mar; 500(1-2):236-44. PubMed ID: 26802494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems.
    Wright L; Wignall A; Jõemetsa S; Joyce P; Prestidge CA
    Drug Deliv Transl Res; 2023 Apr; 13(4):1088-1101. PubMed ID: 36520273
    [TBL] [Abstract][Full Text] [Related]  

  • 44. POZylation: a new approach to enhance nanoparticle diffusion through mucosal barriers.
    Mansfield ED; Sillence K; Hole P; Williams AC; Khutoryanskiy VV
    Nanoscale; 2015 Aug; 7(32):13671-9. PubMed ID: 26214263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.
    Piazza J; Hoare T; Molinaro L; Terpstra K; Bhandari J; Selvaganapathy PR; Gupta B; Mishra RK
    Eur J Pharm Biopharm; 2014 May; 87(1):30-9. PubMed ID: 24560967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transport properties and aggregation phenomena of polyoxyethylene sorbitane monooleate (polysorbate 80) in pig gastrointestinal mucin and mucus.
    Lafitte G; Thuresson K; Jarwoll P; Nydén M
    Langmuir; 2007 Oct; 23(22):10933-9. PubMed ID: 17894509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Theranostic vesicles based on bovine serum albumin and poly(ethylene glycol)-block-poly(L-lactic-co-glycolic acid) for magnetic resonance imaging and anticancer drug delivery.
    Liu Q; Zhu H; Qin J; Dong H; Du J
    Biomacromolecules; 2014 May; 15(5):1586-92. PubMed ID: 24690007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PEGylation for enhancing nanoparticle diffusion in mucus.
    Huckaby JT; Lai SK
    Adv Drug Deliv Rev; 2018 Jan; 124():125-139. PubMed ID: 28882703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and characterization of pH-responsive and folated nanoparticles based on self-assembled brush-like PLGA/PEG/AEMA copolymer with targeted cancer therapy properties: A comprehensive kinetic study.
    Khoee S; Rahmatolahzadeh R
    Eur J Med Chem; 2012 Apr; 50():416-27. PubMed ID: 22397922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
    Kim SH; Jeong JH; Chun KW; Park TG
    Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
    Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
    Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers.
    Vassiliou AA; Papadimitriou SA; Bikiaris DN; Mattheolabakis G; Avgoustakis K
    J Control Release; 2010 Dec; 148(3):388-95. PubMed ID: 20869413
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines.
    Youm I; Youan BB
    Hear Res; 2013 Oct; 304():7-19. PubMed ID: 23747541
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse.
    Maisel K; Ensign L; Reddy M; Cone R; Hanes J
    J Control Release; 2015 Jan; 197():48-57. PubMed ID: 25449804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The oral cavity as a biological barrier system: design of an advanced buccal in vitro permeability model.
    Teubl BJ; Absenger M; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
    Eur J Pharm Biopharm; 2013 Jun; 84(2):386-93. PubMed ID: 23291061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
    Conte G; Costabile G; Baldassi D; Rondelli V; Bassi R; Colombo D; Linardos G; Fiscarelli EV; Sorrentino R; Miro A; Quaglia F; Brocca P; d'Angelo I; Merkel OM; Ungaro F
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7565-7578. PubMed ID: 35107987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Undefined role of mucus as a barrier in ocular drug delivery.
    Ruponen M; Urtti A
    Eur J Pharm Biopharm; 2015 Oct; 96():442-6. PubMed ID: 25770770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.